Evidence map›Paper›PMID 28382527›Full record

ArticleWiener klinische Wochenschrift2017

Multiple thrombophilia mutations as a possible cause of premature myocardial infarction.

Gabriela Dostálová, Jan Bělohlávek, Zuzana Hlubocká, Kristýna Bayerová, Petra Bobčiková, Tomáš Kvasnička, Jan Kvasnička, Aleš Linhart, Debora Karetová

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Wiener klinische Wochenschrift, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Gabriela DostálováSecond Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University in Prague, U Nemocnice 2, 12808, Prague, Czech Republic. gabriela.dostalova@vfn.cz.ORCID http://orcid.org/0000-0003-4809-1274
Jan BělohlávekSecond Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University in Prague, U Nemocnice 2, 12808, Prague, Czech Republic.
Zuzana HlubockáSecond Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University in Prague, U Nemocnice 2, 12808, Prague, Czech Republic.
Kristýna BayerováSecond Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University in Prague, U Nemocnice 2, 12808, Prague, Czech Republic.
Petra BobčikováInstitute of Medical Biochemistry and Laboratory Diagnostics, the Thrombosis Center, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
Tomáš KvasničkaInstitute of Medical Biochemistry and Laboratory Diagnostics, the Thrombosis Center, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
Jan KvasničkaInstitute of Medical Biochemistry and Laboratory Diagnostics, the Thrombosis Center, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
Aleš LinhartSecond Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University in Prague, U Nemocnice 2, 12808, Prague, Czech Republic.
Debora KaretováSecond Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University in Prague, U Nemocnice 2, 12808, Prague, Czech Republic.
Charles University · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The incidence of acute myocardial infarction (AMI) increases with clustering of predisposing risk factors. In younger subjects with a positive family history of AMI occurring in relatives under the age of 60 years without obvious risk factors for atherosclerosis, there is a potential for strong inherited traits contributing to the risk of coronary disease. Among them there is increasing evidence that hereditary thrombophilia may play a major role. We present a unique case of a patient developing AMI at the age of 48 years. In this patient, without traditional risk factors for atherosclerosis, eight mutations and polymorphisms in six different genes were identified: polymorphism of factor V Leiden (1691 GA), factor II prothrombin (20210 GA), methylenetetrahydrofolate reductase (MTHFR, 677 CT and 1298 AC), plasminogen activator inhibitor 1 (PAI-1) polymorphism 4G/5G and glycoprotein VI (GP6, 13254 TC, Ser219Pro). All could be involved in the pathogenesis of the arterial thrombosis. Although such associations are extremely rare, it underlines the importance of thrombophilia assessment in cases with otherwise unexpected coronary disease occurring at young age. According to our experience, in the case of documented hereditary thrombophilia lineal relatives should be examined and/or followed up.

Indexed as

DNA Mutational AnalysisAntigensAtherosclerosisFactor VGenetic Predisposition to DiseaseHumansMaleMethylenetetrahydrofolate Reductase (NADPH2)Middle AgedMyocardial InfarctionPlasminogen Activator Inhibitor 1Platelet Membrane GlycoproteinsPolymorphism, GeneticProthrombinRisk FactorsThrombophiliaAntigensfactor II clotting antigenFactor Vfactor V LeidenMethylenetetrahydrofolate Reductase (NADPH2)MTHFR protein, humanPlasminogen Activator Inhibitor 1Platelet Membrane Glycoproteinsplatelet membrane glycoprotein VIProthrombinSERPINE1 protein, humanAtherosclerosisMyocardial infarctionPolymorphismThrombophilia

Identifiers

PMID28382527
OpenAlexW2604272604

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.